Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Quantum-Coherent Optoelectronic Platform for Ultra-Early Detection of Oncometabolites

Objectif

Early cancer detection remains a critical unmet medical need, as most diagnostic technologies only identify tumours after macroscopic lesions have formed. Mutations in isocitrate dehydrogenase (IDH1/2) produce the oncometabolite D-2-hydroxyglutarate (D-2HG), an early biochemical marker detectable in blood and urine. Current detection methods rely on chromatographic or enzymatic assays that require complex equipment, extensive sample preparation, and often struggle with sensitivity at very low concentrations. Q-SENSE-EDO introduces a novel diagnostic approach based on quantum-engineered molecular sensing. Instead of measuring fluorescence intensity or relying on genomic amplification, the proposal aims to detect biological targets by observing changes in excited-state dynamics within molecular systems. The interaction between D-2HG and a specially engineered molecular interface is expected to cause measurable changes in excited-state lifetime, vibronic coherence, and non-radiative decay pathways. These perturbations can be measured using time-resolved optoelectronic readouts, offering a physics-based sensing mechanism. The project builds on discoveries from the ERC Advanced Grant EXCITED, which demonstrated the ability to engineer molecular sensitizers with controlled excited-state dynamics and coherent photophysical behaviour. Q-SENSE-EDO will translate these findings into a proof-of-concept diagnostic platform by developing biofunctional quantum-coherent dyes, characterising their interaction with D-2HG using multidimensional time-resolved spectroscopy, and implementing a simplified lifetime-based classification model compatible with clinical instruments. If successful, Q-SENSE-EDO will define quantum-state perturbation as a new biosensing principle, opening a technological frontier at the intersection of quantum chemistry, photonics, and biomedical diagnostics while establishing a robust intellectual property portfolio for quantum-enabled sensing technologies.

Champ scientifique (EuroSciVoc)

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2026-POC

Voir tous les projets financés au titre de cet appel

Institution d’accueil

FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA
Contribution nette de l'UE
€ 150 000,00
Coût total
Aucune donnée

Bénéficiaires (1)